In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...

Aging is a privilege, but it also brings risks—including an increased likelihood of developing age-related diseases including ...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated ...

HER2-positive (HER2+) breast cancer treatments come with a range of unpleasant side effects. However, there are strategies ...

In this video, Aruna Padmanabhan, MD, discusses the effectiveness of cyclin-dependent kinase inhibitors in the treatment of metastatic hormone-positive breast cancer.

Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive ...

She had no family history of cancer. So when she experienced some swelling in her breast near the end of what she called “a textbook-easy pregnancy” with her third child, she and her doctors ...

Jan. 21, 2025 -- The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed. The drug ...

A series of recent studies also suggest that CH may play a role in the outcomes of patients with solid tumors, including breast cancer. Here, we review the clinical and biological data that underlie ...

Its current publication date reflects a new medical review. “I’m sorry, but your breast cancer has spread to your liver.” These may be the words my oncologist used when he told me that I was ...

The Canadian Cancer Society estimates about one in eight Canadian women will develop breast cancer during their lifetime. One in 36 women will die from it. Partly in response to a study that ...